100 results on '"Espin, J"'
Search Results
2. Wildfire Impacts on Soil Microbiomes: Potential for Disruptions to Nitrogen-Cycling Bacteria.
3. Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework
4. Enhanced Spin Tunneling in a Molecular Magnet Mixed with a Superconductor
5. Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab
6. Investigation on the aroma of wines from seven clones of Monastrell grapes
7. Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries
8. HPR95 Opportunities and Challenges for Value Added Medicines: Results of a Scoping Research Based on Expert Interviews
9. There Is Differential Loss of Pyramidal Cells from the Human Hippocampus with Survival after Blunt Head Injury
10. Meta-analysis of the effects of foods and derived products containing ellagitannins and anthocyanins on cardiometabolic biomarkers: analysis of factors influencing variability of the individual responses
11. PRO96 A Multi-Stakeholder Multicriteria Decision Analysis in Rare Diseases: Reimbursement Criteria for Orphan Drugs in Spain (FinMHU-MCDA study)
12. PNS270 Real World Evidence and Risk-sharing Agreements: Shaken, Not Stirred
13. PNS108 Proposal for a Core Evaluation Framework of Value Added Medicines
14. PNS26 Appropriate Indices of Inflation to Update Prices and Unit Costs of Healthcare Goods and Services for Use in Economic Evaluation
15. PNS95 INTERNATIONAL REFERENCE PRICING: ACCEPTANCE AND AVOIDANCE BEHAVIORS AFFECTING PATIENT ACCESS AND INNOVATION IN U.S. AND BEYOND
16. Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial
17. Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries.
18. PMU29 ECONOMIC EVALUATION FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURES INFECTIONS (ABSSSI) FROM THE NATIONAL PAYER PERSPECTIVE: INTRODUCTION OF A NEW TREATMENT INTO THE PATIENT JOURNEY. SIMULATION IN 3 EUROPEAN COUNTRIES
19. HPR209 Criteria for Decision-Making on Drug Financing in Spain: How Do We Measure Them and What Relevance Does Each One Have?
20. HPR65 Pricing and Reimbursement Mechanisms for Advanced Therapeutic Medicinal Products in 20 Countries.
21. PCP23 - DOES THE EUROPEAN UNION (EU) NEED EUROPEAN HTA OR EUROPEAN PROCUREMENT?
22. PCP15 - WHY EUROPEAN CROSS-BORDER INITIATIVES ON DRUG PROCUREMENT MAY FAIL?
23. PCN308 - DO HEALTH TECHNOLOGY APPRAISALS HAVE AN IMPACT?: A COMPARISON OF CENTRALIZED AND REGIONAL APPROACHES
24. HT3 - DESCRIPTION AND COMPARISON OF EUROPEAN CROSS-BORDER INITIATIVES ON DRUG PROCUREMENT
25. PDB9 - Costo De La Diabetes Mellitus En El Sistema De Salud Colombiano
26. PSS15 - Economic Evaluation for The Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) From The NHS Perspective: A Spending Predictor Model for Italy, Romania and Spain
27. PHP70 - Forecasting Pharmaceutical Expenditure In Europe: Adjusting For The Impact Of Rebates And Discounts
28. PHS36 - Study Care Costs and Use of Health Technologies for Patients with Hemophilia a Health System Affiliates in Colombia
29. PHP365 - Unlocking Established Products Patient and Societal Value in Additional Indications
30. PHP284 - Multi-Criteria Decision Analysis (MCDA): Common Tools for Different Needs Supporting Healthcare Decision Making in Spain
31. Glycation of ApoA-I links diabetes and CVD
32. Planning of dynamic mobile optical virtual network infrastructures supporting cloud services.
33. A converged network architecture for energy efficient mobile cloud computing.
34. HT4 - Regional Versus Centralized Hta: Implications for the Assessment of Cancer Drugs
35. A multi-tenancy model based on resource capabilities and Ownership for infrastructure management.
36. An analytical model of the service provisioning time within the harmony network service plane.
37. Street CORNERS: Real-Time Contextual Representation of Sensor Network Data for Environmental Trend Identification.
38. PHP30 Biosimilars in the European Market
39. Inclusion body-like organization of protein-based artificial viruses for gene therapy
40. PHP323 - Extension of Indication With Mature Products: Toward More Incentives Rewarding Innovation?
41. HT4 Regional Versus Centralized Hta: Implications for the Assessment of Cancer Drugs
42. PHP323 Extension of Indication With Mature Products: Toward More Incentives Rewarding Innovation?
43. 717: EPIDEMIOLOGY OF PULMONARY ARTERIAL HYPERTENSION IN A SPANISH PAEDIATRIC POPULATION: DATA FROM THE SPANISH REGISTRY FOR PAEDIATRIC PULMONARY HYPERTENSION (REHIPED) AND SPANISH REGISTRY FOR PULMONARY ARTERIAL HYPERTENSION IN ADULTS (REHAP).
44. Cost transferability problems in economic evaluation as a framework for an European health care and social costs database
45. Resonant spin tunneling in randomly oriented nanospheres of Mn12 acetate.
46. Pandemic influenza control in Europe and the constraints resulting from incoherent public health laws
47. Extension of Indication With Mature Products: Toward More Incentives Rewarding Innovation?
48. Regional Versus Centralized Hta: Implications for the Assessment of Cancer Drugs.
49. Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature.
50. Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.